DAAN Bio Therapeutics announced that it has received KRW 23,000,000,000 in round of funding co-led by new investors Solasta Ventures, Inc, Paratus Investment Inc., Timefolio Asset Management Co.,Ltd, Company K Partners Limited, Atinum Investment Co., Ltd, Stonebridge Ventures, DAYLI Partners Co., Ltd., KB Investment Co., Ltd, Solidus Investment Co., Ltd., Heungkuk Securities Co., Ltd., Shinhan Capital Co., Ltd. and FuturePlay on January 29, 2024.